A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor‐β and vascular endothelial growth factor signalling
Yuqing Liu(Sichuan Normal University), Tao Ye(Third People's Hospital of Chengdu), Eric Lik Hang Lui(Hong Kong Polytechnic University), Shoubin Tang(Peking University), Zhengshuang Xu(Peking University), Scott L. Friedman(Icahn School of Medicine at Mount Sinai), Shuqin Kwong(Hong Kong Polytechnic University), Hui Zhang(Heilongjiang University of Chinese Medicine), Jianing Wang(Hong Kong Polytechnic University), Zhuo Wang(Hong Kong Polytechnic University), Furong Li(Jinan University), Qi Ren(Army Medical University), Xingen Wang(Jinan University), Ling Ji(Jinan University), Shuyan Zhou(Georgetown University), Wingchi Lam(Hong Kong Polytechnic University)
Cited by 94
Related Papers
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
|Journal of Biological Chemistry|2000|2.1k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
Focal Gains of <i>VEGFA</i> and Molecular Classification of Hepatocellular Carcinoma
|Cancer Research|2008|712